- Report
- January 2026
- 314 Pages
Global
From €2217EUR$2,500USD£1,931GBP
- Report
- February 2026
- 250 Pages
Global
From €3982EUR$4,490USD£3,469GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2660EUR$3,000USD£2,318GBP
- Report
- March 2025
- 211 Pages
Global
From €4124EUR$4,650USD£3,592GBP
- Report
- December 2024
- 100 Pages
Global
From €5276EUR$5,950USD£4,597GBP
- Report
- October 2024
- 200 Pages
Global
From €3325EUR$3,750USD£2,897GBP
- Report
- April 2023
- 501 Pages
Global
From €4434EUR$5,000USD£3,863GBP
- Report
- June 2024
- 200 Pages
Global
From €7050EUR$7,950USD£6,142GBP
- Report
- January 2022
- 60 Pages
Global
From €3503EUR$3,950USD£3,052GBP
From €3104EUR$3,500USD£2,704GBP
- Clinical Trials
- April 2025
- 550 Pages
Global
From €4434EUR$5,000USD£3,863GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1774EUR$2,000USD£1,545GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1774EUR$2,000USD£1,545GBP
- Report
- August 2024
- 150 Pages
Global
From €2473EUR$2,789USD£2,155GBP
- Report
- January 2025
- 135 Pages
Global
From €3546EUR$3,999USD£3,090GBP
- Report
- February 2024
- 112 Pages
Global
From €4212EUR$4,750USD£3,670GBP
- Report
- March 2025
- 222 Pages
Global
From €2217EUR$2,500USD£1,931GBP
- Report
- April 2023
- 326 Pages
Global
From €3192EUR$3,600USD£2,781GBP
- Report
- April 2023
- 128 Pages
Asia Pacific
From €1330EUR$1,500USD£1,159GBP
- Report
- April 2023
- 112 Pages
North America
From €1330EUR$1,500USD£1,159GBP

Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. Oncology drugs are used to treat this type of cancer, and the stomach cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of stomach cancer, and can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as chemotherapy and radiation therapy.
The stomach cancer drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this type of cancer. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to improve the treatment of stomach cancer. Show Less Read more